Identification of polcalcin as a novel allergen of Amaranthus retroflexus pollen.


Journal

Allergologia et immunopathologia
ISSN: 1578-1267
Titre abrégé: Allergol Immunopathol (Madr)
Pays: Singapore
ID NLM: 0370073

Informations de publication

Date de publication:
Historique:
received: 09 08 2018
revised: 13 12 2018
accepted: 29 12 2018
pubmed: 17 2 2019
medline: 14 1 2020
entrez: 17 2 2019
Statut: ppublish

Résumé

Amaranthus retroflexus (Redroot Pigweed) is one of the main sources of allergenic pollens in temperate areas. Polcalcin is a well-known panallergen involved in cross-reactivity between different plants. The aim of this study was the molecular cloning and expression of polcalcin, as well as evaluating its IgE-reactivity with A. retroflexus sensitive patients' sera. Allergenic extract was prepared from A. retroflexus pollen and the IgE-reactivity profile was determined by ELISA and immunoblotting using sera from twenty A. retroflexus sensitive patients. Polcalcin-coding sequence was amplified by conventional PCR method and the product was inserted into pET-21b(+) vector. The recombinant protein was expressed in E. coli BL21 and purified by metal affinity chromatography. The IgE-binding capability of the recombinant protein was analyzed by ELISA and immunoblotting assays, and compared with crude extract. Of 20 skin prick test positive patients, 17 patients were positive in IgE-specific ELISA. Western blotting confirmed that approximately 53% of ELISA positive patients reacted with 10kDa protein in crude extract. The A. retroflexus polcalcin gene, encoding to 80 amino acid residues was cloned and expressed as a soluble protein and designated as Ama r 3. The recombinant polcalcin showed rather identical IgE-reactivity in ELISA and western blotting with 10kDa protein in crude extract. These results were confirmed by inhibition methods, too. The recombinant form of A. retroflexus polcalcin (Ama r 3) could be easily produced in E. coli in a soluble form and shows rather similar IgE-reactivity with its natural counterpart.

Identifiants

pubmed: 30770138
pii: S0301-0546(19)30005-9
doi: 10.1016/j.aller.2018.12.006
pii:
doi:

Substances chimiques

Allergens 0
Antigens, Plant 0
Calcium-Binding Proteins 0
Plant Extracts 0
Recombinant Proteins 0
Immunoglobulin E 37341-29-0

Types de publication

Journal Article

Langues

eng

Sous-ensembles de citation

IM

Pagination

357-364

Informations de copyright

Copyright © 2019 SEICAP. Published by Elsevier España, S.L.U. All rights reserved.

Auteurs

M Vakili Moghaddam (M)

Immunology Research Center, Iran University of Medical Sciences, Tehran, Iran; Department of Immunology, School of Medicine, Shahrekord University of Medical Sciences, Shahrekord, Iran.

M Fallahpour (M)

Department of Allergy and Clinical Immunology, Iran University of Medical Sciences, Tehran, Iran.

M Mohammadi (M)

Persian Gulf Marine Biotechnology Research Center, Persian Gulf Biomedical Sciences Research Institute, Bushehr University of Medical Sciences, Bushehr, Iran.

F S Rasi Varaee (FS)

Immunology Research Center, Iran University of Medical Sciences, Tehran, Iran.

K Mokhtarian (K)

Clinical Biochemistry Research Center, Basic Health Sciences Institute, Shahrekord University of Medical Sciences, Shahrekord, Iran.

M Khoshmirsafa (M)

Immunology Research Center, Iran University of Medical Sciences, Tehran, Iran; Department of Immunology, School of Medicine, Iran University of Medical Sciences, Tehran, Iran.

R Jafari (R)

Department of Immunology, School of Medicine, Shahroud University of Medical Sciences, Shahroud, Iran.

N Shirzad (N)

Department of Immunology, School of Medicine, Shahrekord University of Medical Sciences, Shahrekord, Iran.

R Falak (R)

Immunology Research Center, Iran University of Medical Sciences, Tehran, Iran; Department of Immunology, School of Medicine, Iran University of Medical Sciences, Tehran, Iran. Electronic address: Falak.r@iums.ac.ir.

Articles similaires

[Redispensing of expensive oral anticancer medicines: a practical application].

Lisanne N van Merendonk, Kübra Akgöl, Bastiaan Nuijen
1.00
Humans Antineoplastic Agents Administration, Oral Drug Costs Counterfeit Drugs

Smoking Cessation and Incident Cardiovascular Disease.

Jun Hwan Cho, Seung Yong Shin, Hoseob Kim et al.
1.00
Humans Male Smoking Cessation Cardiovascular Diseases Female
Humans United States Aged Cross-Sectional Studies Medicare Part C
1.00
Humans Yoga Low Back Pain Female Male

Classifications MeSH